Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19

PHASE3CompletedINTERVENTIONAL

Enrollment

356

Participants

Timeline

Start Date

April 4, 2020

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions

SARS-CoV-2 Infection

Interventions

DRUG

Emtricitabine/Tenofovir Disoproxil Fumarate 200 MG-245 MG Oral Tablet [TRUVADA]

Main randomization

DRUG

Baricitinib + dexamethasone

Rescue randomization

DRUG

Dexamethasone

Rescue randomization

Trial Locations (1)

Hospital Universitario La Paz, Madrid

All Listed Sponsors

lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT04890626 - Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19 | Biotech Hunter | Biotech Hunter